Sulfonylurea - an overview | ScienceDirect Topics
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus | Nature Reviews Endocrinology
![PDF] Octreotide's Role in the Management of Sulfonylurea-Induced Hypoglycemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/20674f5c176f2d5e50e1700f5203dd7ef2385e5b/3-Figure1-1.png "PDF] Octreotide's Role in the Management of Sulfonylurea-Induced Hypoglycemia | Semantic Scholar")
PDF] Octreotide's Role in the Management of Sulfonylurea-Induced Hypoglycemia | Semantic Scholar
![PDF] Sulfonylureas and their use in clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e7310d32e6f18361b1a92bbe57a4a058be2c45a/3-Figure1-1.png "PDF] Sulfonylureas and their use in clinical practice | Semantic Scholar")
PDF] Sulfonylureas and their use in clinical practice | Semantic Scholar
Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes | SpringerLink
Sulfonylureas: Site of Action, Pharmacokinetics & Dose Conversion
References in The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents - Diabetes Research and Clinical Practice
![oral_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/tzds.png "oral_hypoglycemic_drugs [TUSOM | Pharmwiki]")
oral_hypoglycemic_drugs [TUSOM | Pharmwiki]
Oral hypoglycemic drugs - ppt download
Sulfonylurea action re‐revisited - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. - Abstract - Europe PMC
Treatment of Diabetes Mellitus: General Goals and Clinical Practice Management | Revista Española de Cardiología
The Molecular Mechanism of the Insulin-mimetic/sensitizing Activity of the Antidiabetic Sulfonylurea Drug Amaryl | Molecular Medicine | Full Text
The Sulfonylurea Controversy: More Questions From the Heart - ScienceDirect
Sulfonylurea - Wikipedia
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas | SpringerLink
![oral_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/metformin.png "oral_hypoglycemic_drugs [TUSOM | Pharmwiki]")
oral_hypoglycemic_drugs [TUSOM | Pharmwiki]
Glimepiride
Mechanism of action of sulfonylureas on pancreatic β‑cells and... | Download Scientific Diagram
![PDF] Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9925a3a7f2be2150e2fd73bfdd2a4ceedee24f8/6-Figure1-1.png "PDF] Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force | Semantic Scholar")
PDF] Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force | Semantic Scholar
Cooperation between cAMP signalling and sulfonylurea in insulin secretion - Shibasaki - 2014 - Diabetes, Obesity and Metabolism - Wiley Online Library
JCI - β Cell–intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion
